British startup Respiro Diagnostics announced on Wednesday that it has raised £1 million ($1.34 million) in a pre-seed funding round to develop a breath-based test for respiratory diseases. The round ...
Of the roughly 1 million disputes taken through the law's arbitration process in Q2 2025, around 129,000 were for lab codes, with payments for basic tests averaging hundreds of dollars.
The test, along with other research-use tests for neurodegenerative disease, run on the Danaher subsidiary's DxI 9000 Immunoassay Analyzer system.
Last week, readers were most interested in a rumor about a possible sale of QuidelOrtho's point-of-care business, which sent its stock soaring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results